Home Newsfeeds Wolfe Research Downgrades Cowen to Peer Perform

Wolfe Research Downgrades Cowen to Peer Perform

Wolfe Research analyst Steven Chubak downgrades Cowen (NASDAQ:COWN) from Outperform to Peer Perform.

byBenzinga Newsdesk

August 2, 2022

1 minute read

Wolfe Research analyst Steven Chubak downgrades Cowen (NASDAQ:COWN) from Outperform to Peer Perform.

Biodexa Completes Recruitment Of Cohort A In Study Of MTX110 In Patients With Recurrent Glioblastoma

By Benzinga Newsdesk

October 3, 8:31 AM

Biodexa Pharmaceuticals PLC("Biodexa" or the "Company")Biodexa Completes Recruitment of Cohort A in Study of MTX110 in Patients with Recurrent GlioblastomaBiodexa Pharmaceuticals PLC, (NASDAQ:BDRX), a clinical stage

BDRX

Morgan Stanley Says ‘Spotify The Business’ Has Joined ‘Spotify The Product’ In Delivering For Shareholders

By Shivani Kumaresan

October 25, 3:32 PM

Morgan Stanley analyst

AAPL

Broadcom’s Tech Dominance Affirmed by JPMorgan Analyst; Forecasts Company Will Lead AI and Cloud Revolution

By Anusuya Lahiri

February 6, 3:11 PM

JPMorgan analyst initiates coverage of Broadcom with Overweight rating and $1,550 price target. Broad strengths in semiconductors and software.

AVGO

Raymond James Downgrades Regions Financial to Market Perform

By Benzinga Newsdesk

November 21, 7:22 AM

Raymond James analyst Michael Rose downgrades Regions Financial (NYSE:RF) from Outperform to Market Perform.

Wolfe Research Downgrades Cowen to Peer Perform

Related Posts

Biodexa Completes Recruitment Of Cohort A In Study Of MTX110 In Patients With Recurrent Glioblastoma

Morgan Stanley Says ‘Spotify The Business’ Has Joined ‘Spotify The Product’ In Delivering For Shareholders

Broadcom’s Tech Dominance Affirmed by JPMorgan Analyst; Forecasts Company Will Lead AI and Cloud Revolution

Raymond James Downgrades Regions Financial to Market Perform